Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 3
1966 16
1967 20
1968 36
1969 50
1970 38
1971 38
1972 42
1973 59
1974 53
1975 81
1976 104
1977 68
1978 93
1979 114
1980 115
1981 120
1982 162
1983 157
1984 172
1985 153
1986 172
1987 186
1988 144
1989 146
1990 125
1991 118
1992 90
1993 82
1994 69
1995 71
1996 48
1997 48
1998 47
1999 42
2000 40
2001 38
2002 43
2003 47
2004 37
2005 41
2006 21
2007 35
2008 34
2009 27
2010 35
2011 33
2012 38
2013 46
2014 34
2015 34
2016 34
2017 41
2018 29
2019 11
2020 25
2021 26
2022 19
2023 8

Text availability

Article attribute

Article type

Publication date

Search Results

3,763 results

Results by year

Filters applied: . Clear all
Page 1
Reduction of PTSD Symptoms With Pre-Reactivation Propranolol Therapy: A Randomized Controlled Trial.
Brunet A, Saumier D, Liu A, Streiner DL, Tremblay J, Pitman RK. Brunet A, et al. Am J Psychiatry. 2018 May 1;175(5):427-433. doi: 10.1176/appi.ajp.2017.17050481. Epub 2018 Jan 12. Am J Psychiatry. 2018. PMID: 29325446 Clinical Trial.
The hypothesis predicted a significant treatment effect of trauma reactivation with propranolol compared with trauma reactivation with placebo in reducing PTSD symptoms on both the Clinician-Administered PTSD Scale (CAPS) and the patient-rated PTSD Checklist-Specific (PCL- …
The hypothesis predicted a significant treatment effect of trauma reactivation with propranolol compared with trauma reactivation wit …
Status of propranolol for treatment of infantile hemangioma and description of a randomized clinical trial.
Menezes MD, McCarter R, Greene EA, Bauman NM. Menezes MD, et al. Ann Otol Rhinol Laryngol. 2011 Oct;120(10):686-95. doi: 10.1177/000348941112001010. Ann Otol Rhinol Laryngol. 2011. PMID: 22097156 Review.
Our secondary objective was to describe a randomized, controlled, single-blinded trial comparing propranolol to prednisolone for treatment of IH. METHODS: Ovid Medline and PubMed searches were completed for the MeSH keywords "propranolol" and "hemangioma." ...Fastid …
Our secondary objective was to describe a randomized, controlled, single-blinded trial comparing propranolol to prednisolone for trea …
Controlled clinical trial of propranolol alone and in combination with dilazep in patients with angina pectoris.
Biswas NR, Pandhi P, Wahi PL, Sharma PL. Biswas NR, et al. Int J Clin Pharmacol Ther Toxicol. 1990 Jun;28(6):241-4. Int J Clin Pharmacol Ther Toxicol. 1990. PMID: 2198233 Clinical Trial.
The present study was performed to see if the combined treatment with propranolol and dilazep offers any advantage over monotherapy with propranolol alone in angina of effort. ...Propranolol in combination with dilazep produced more reduction in these paramet …
The present study was performed to see if the combined treatment with propranolol and dilazep offers any advantage over monotherapy w …
Trigeminovascular effects of propranolol in men and women, role for sex steroids.
Rubio-Beltrán E, Schoon RM, van den Berg J, Schuiling-Veninga CCM, Koch BCP, Villalón CM, Versmissen J, Danser AHJ, van den Meiracker AH, Ibrahimi K, MaassenVanDenBrink A. Rubio-Beltrán E, et al. Ann Clin Transl Neurol. 2022 Sep;9(9):1405-1416. doi: 10.1002/acn3.51640. Epub 2022 Aug 27. Ann Clin Transl Neurol. 2022. PMID: 36029132 Free PMC article. Clinical Trial.
OBJECTIVE: Assess whether propranolol modulates the trigeminovascular system in both men and women. ...INTERPRETATION: Propranolol (80 mg) inhibits capsaicin-induced increases in dermal blood flow in a sex-dependent manner. ...
OBJECTIVE: Assess whether propranolol modulates the trigeminovascular system in both men and women. ...INTERPRETATION: Propranolol …
The use of propranolol in adult burn patients: Safety and outcome influence.
Lam NN, Khanh PQ, An NH. Lam NN, et al. Burns. 2022 Jun;48(4):767-773. doi: 10.1016/j.burns.2021.08.024. Epub 2021 Aug 31. Burns. 2022. PMID: 34895792 Clinical Trial.
OBJECTIVES: This study investigated safety and effect of propranolol on adult patients with severe burn. METHODS: A prospective study was conducted on 124 severely adult burn patients who were randomly divided into propranolol and non-propranolol group. ...Si …
OBJECTIVES: This study investigated safety and effect of propranolol on adult patients with severe burn. METHODS: A prospective study …
COMT Genotype and Efficacy of Propranolol for TMD Pain: A Randomized Trial.
Slade GD, Fillingim RB, Ohrbach R, Hadgraft H, Willis J, Arbes SJ Jr, Tchivileva IE. Slade GD, et al. J Dent Res. 2021 Feb;100(2):163-170. doi: 10.1177/0022034520962733. Epub 2020 Oct 8. J Dent Res. 2021. PMID: 33030089 Free PMC article. Clinical Trial.
Propranolol is a nonselective beta-adrenergic receptor antagonist that is efficacious in reducing facial pain. ...Cumulative response curves confirmed greater (P = 0.003) efficacy for G:G homozygotes (%AUC difference = 43.7, 95%CL = 15.4, 72.1) than for A:A homozygotes (%A …
Propranolol is a nonselective beta-adrenergic receptor antagonist that is efficacious in reducing facial pain. ...Cumulative response …
Double blind cross-over clinical trial of acebutolol and propranolol in angina pectoris.
Pandhi P, Sethi V, Sharma BK, Wahi PL, Sharma PL. Pandhi P, et al. Int J Clin Pharmacol Ther Toxicol. 1985 Nov;23(11):598-600. Int J Clin Pharmacol Ther Toxicol. 1985. PMID: 3908331 Clinical Trial.
Twenty-four patients with classical angina of effort completed this double-blind cross-over clinical trial of acebutolol and propranolol. Both acebutolol (100-400 mg) and propranolol (40-160 mg) three times a day produced a significant reduction in the incidence of …
Twenty-four patients with classical angina of effort completed this double-blind cross-over clinical trial of acebutolol and propranolol …
A comparative trial of flunarizine and propranolol in the prevention of migraine.
Shimell CJ, Fritz VU, Levien SL. Shimell CJ, et al. S Afr Med J. 1990 Jan 20;77(2):75-7. S Afr Med J. 1990. PMID: 2404346 Clinical Trial.
The calcium-entry blocker flunarizine (Sibelium; Janssen) was compared with the beta-adrenoreceptor-blocking agent propranolol in the prophylaxis of migraine. Fifty-eight patients were entered into a double-blind 4-month treatment trial. ...Both flunarizine and proprano …
The calcium-entry blocker flunarizine (Sibelium; Janssen) was compared with the beta-adrenoreceptor-blocking agent propranolol in the …
D-Propranolol and anxiety.
Bonn JA, Turner P. Bonn JA, et al. Lancet. 1971 Jun 26;1(7713):1355-6. doi: 10.1016/s0140-6736(71)91915-5. Lancet. 1971. PMID: 4103419 Clinical Trial. No abstract available.
Comparative trial of atenolol and propranolol in hyperthyroidism.
McDevitt DG, Nelson JK. McDevitt DG, et al. Br J Clin Pharmacol. 1978 Sep;6(3):233-7. doi: 10.1111/j.1365-2125.1978.tb04590.x. Br J Clin Pharmacol. 1978. PMID: 356867 Free PMC article. Clinical Trial.
1 The use of atenolol, a cardioselective beta-adrenoceptor antagonist, in the management of hyperthyroidism has been studied by comparing it with propranolol. 2 In a double-blind cross-over trial, atenolol (50 mg), propranolol (40 mg) and placebo 4 times daily for 1 …
1 The use of atenolol, a cardioselective beta-adrenoceptor antagonist, in the management of hyperthyroidism has been studied by comparing it …
3,763 results